Search

everythinglearnresearchcommunity

for

Search:↓

Combining dermoscopy and calcium fluorescent white staining improves diagnosis and treatment of hair fungal infections.

Leporacarus gibbus mite was found in a domestic rabbit in Espírito Santo, Brazil, for the first time.

The patient had paraneoplastic pemphigus without mucosal involvement.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

BST2 protein and certain T cells increase in early alopecia areata.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Mogamulizumab can cause hair loss and skin rashes.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

A new type of nerve cell involved in itch perception was discovered.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Ixekizumab effectively treats generalized pustular psoriasis.